Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 17-(cyclobutylmethyl)morphinan-3,14-diol
2. Apo-butorphanol
3. Bc 2627
4. Bc-2627
5. Bc2627
6. Beforal
7. Butorphanol
8. Butorphanol Tartrate
9. Dolorex
10. Moradol
11. Stadol
12. Stadol Ns
13. Torbugesic
1. Butorphanol Tartrate
2. 58786-99-5
3. Butorphanol (+)-tartrate Salt
4. Stadol (tn)
5. Butorphanol Tartrate Salt
6. Butorphanol Tartrate (jan/usp)
7. Akos015994595
8. Hs-0001
9. Butorphanol (+)-tartrate Salt, >=99%
10. D00837
11. 786b995
12. Butorphanol Tartrate, United States Pharmacopeia (usp) Reference Standard
1. Butorfanol
2. Torate
3. Torbutrol
| Molecular Weight | 477.5 g/mol |
|---|---|
| Molecular Formula | C25H35NO8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 477.23626707 g/mol |
| Monoisotopic Mass | 477.23626707 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
| 2 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Parenteral
Controlled & Modified Release
Solubilizers
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
46
PharmaCompass offers a list of Butorphanol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butorphanol manufacturer or Butorphanol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butorphanol manufacturer or Butorphanol supplier.
PharmaCompass also assists you with knowing the Butorphanol API Price utilized in the formulation of products. Butorphanol API Price is not always fixed or binding as the Butorphanol Price is obtained through a variety of data sources. The Butorphanol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butorfanol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butorfanol, including repackagers and relabelers. The FDA regulates Butorfanol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butorfanol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butorfanol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butorfanol supplier is an individual or a company that provides Butorfanol active pharmaceutical ingredient (API) or Butorfanol finished formulations upon request. The Butorfanol suppliers may include Butorfanol API manufacturers, exporters, distributors and traders.
click here to find a list of Butorfanol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Butorfanol DMF (Drug Master File) is a document detailing the whole manufacturing process of Butorfanol active pharmaceutical ingredient (API) in detail. Different forms of Butorfanol DMFs exist exist since differing nations have different regulations, such as Butorfanol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Butorfanol DMF submitted to regulatory agencies in the US is known as a USDMF. Butorfanol USDMF includes data on Butorfanol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Butorfanol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Butorfanol suppliers with USDMF on PharmaCompass.
A Butorfanol written confirmation (Butorfanol WC) is an official document issued by a regulatory agency to a Butorfanol manufacturer, verifying that the manufacturing facility of a Butorfanol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Butorfanol APIs or Butorfanol finished pharmaceutical products to another nation, regulatory agencies frequently require a Butorfanol WC (written confirmation) as part of the regulatory process.
click here to find a list of Butorfanol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Butorfanol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Butorfanol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Butorfanol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Butorfanol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Butorfanol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Butorfanol suppliers with NDC on PharmaCompass.
Butorfanol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butorfanol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butorfanol GMP manufacturer or Butorfanol GMP API supplier for your needs.
A Butorfanol CoA (Certificate of Analysis) is a formal document that attests to Butorfanol's compliance with Butorfanol specifications and serves as a tool for batch-level quality control.
Butorfanol CoA mostly includes findings from lab analyses of a specific batch. For each Butorfanol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butorfanol may be tested according to a variety of international standards, such as European Pharmacopoeia (Butorfanol EP), Butorfanol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butorfanol USP).
